^
Association details:
| Biomarker: | EGFR D770_N771insGT |
|---|---|
| Cancer: | Non Small Cell Lung Cancer |
| Drug: | Tagrisso (osimertinib) (EGFR inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Case Report: Osimertinib Followed by Osimertinib Plus Bevacizumab, Personalized Treatment Strategy for a Lung Cancer Patient With a Novel EGFR Exon 20 Insertion D770_N771insGT and Multiple Brain Metastases
Published date:
10/25/2021
Excerpt:
Our case suggests that osimertinib alone or in combination with bevacizumab can be a feasible therapeutic option for NSCLC patients with specific EGFRex20ins mutations and brain metastases
